CHAMPION pooled: Cangrelor cuts thrombotic events during PCI

A prespecified pooled analysis of the three CHAMPION trials investigating the intravenous antiplatelet in the setting of PCI has turned up some positive results. Just where and how this drug might square up against other new agents remains an open question.

Source: theHeart.org - September 6, 2013 Category: Cardiology Source Type: news